Elsevier Inc.

SHERPA: Unknown

People

  1. Riely
    Riely
  2. Yu
    Yu
  3. Wu
    Wu
  4. Arcila
    Arcila
  5. Kris
    Kris
  6. Rudin
    Rudin
  7. Zhang
    Zhang
  8. Huang
    Huang
  9. Ladanyi
    Ladanyi
  10. Patel
    Patel

Groups

  1. Department of Medicine (28)
  2. Solid Tumor Oncology Division (28)
  3. Thoracic Oncology (28)
  4. Surgery (12)
  5. Radiation Oncology, Department of (11)
  6. GSK Faculty (10)
  7. Survivorship Research (10)
  8. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (7)
  9. Biostatistics Service (5)
  10. Epidemiology and Biostatistics (5)
Search Within
  1. "Thoracic Oncology"
  2. "2014"
Formats
  1. Journal Article (14)
  2. Meeting Abstract (14)
Groups
  1. Department of Medicine (28)
  2. Solid Tumor Oncology Division (28)
  3. Thoracic Oncology (28)
  4. Surgery (12)
  5. Radiation Oncology, Department of (11)
  6. GSK Faculty (10)

More Groups

People
  1. Gregory Riely (15)
  2. Andreas Rimner (11)
  3. Helena Yu (11)
  4. Abraham Wu (8)
  5. Amanda Foster (7)
  6. Kaitlin Woo (7)

More People

Years
  1. 2014 (28)
Publications
  1. Journal of Thoracic Oncology (13)
  2. International Journal of Radiation Oncology, Biology, Physics (12)
  3. Clinical Lung Cancer (2)
  4. European Journal of Cancer (1)

Results (28)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Emerging science and therapies in non-small-cell lung cancer: Targeting the MET pathway
    Journal Article

    Kris, M. G.; Arenberg, D. A.; Herbst, R. S.; Riely, G. J.
    Clinical Lung Cancer (2014)

    Fulltext@MSK | Save
  • Clinical and in vivo evidence that EGFR S768I mutant lung adenocarcinomas are sensitive to erlotinib
    Journal Article

    Hellmann, M. D.; Reva, B.; Yu, H.; Rusch, V. W.; Rizvi, N. A.; Kris, M. G.; Arcila, M. E.
    Journal of Thoracic Oncology (2014)

    Fulltext@MSK | Save
  • Interim phase 2 results of study CO-1686-008: A phase 1/2 study of the irreversible, mutant selective, EGFR inhibitor rociletinib (CO-1686) in patients with advanced non small cell lung cancer
    Meeting Abstract

    Soria, J.; Sequist, L. V.; Goldman, J. W.; Wakelee, H. A.; Gadgeel, S. M.; Varga, A.; Yu, H. A.; Solomon, B. J.; Ou, S. H.; Papadimitrakopoulou, V.; more...
    European Journal of Cancer (2014)

    Fulltext@MSK | Save
  • Epigenetic analysis of small cell lung cancer defines distinct disease subsets
    Meeting Abstract

    Rudin, C. M.; Connis, N.; Hann, C. L.; Poirier, J. T.
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save
  • Stage III non-small cell lung cancer treated without concurrent chemotherapy: What is the optimal radiation dose?
    Meeting Abstract

    Rimner, A.; Din, S.; Shaikh, F.; Foster, A.; Tyagi, N.; Abi Aad, S.; Paik, P.; Yorke, E. D.; Chaft, J. E.; Gelblum, D. Y.; more...
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save
  • Pattern of failure in metastatic EGFR-mutant NSCLC treated with erlotinib: A role for upfront radiation therapy?
    Meeting Abstract

    Patel, S.; Rimner, A.; Foster, A.; Zhang, Z.; Woo, K. M.; Yu, H. A.; Riely, G. J.; Wu, A. J.
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save
  • Risk of brain metastasis in EGFR-mutant NSCLC treated with erlotinib: A role for prophylactic cranial irradiation?
    Meeting Abstract

    Patel, S.; Rimner, A.; Foster, A.; Zhang, Z.; Woo, K. M.; Yu, H. A.; Riely, G. J.; Wu, A. J.
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save
  • EGFR exon 20 alterations in lung adenocarcinomas and their impact on overall survival and response to EGFR TKI
    Meeting Abstract

    Naidoo, J.; Sima, C. S.; Rodriguez, K.; Busby, N.; Arcila, M. E.; Yu, H. A.
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes for 61 patients with metastatic pulmonary carcinoids
    Meeting Abstract

    Litvak, A. M.; Iyriboz, T.; Zakowski, M.; Woo, K.; Krug, L.; Rudin, C.; Pietanza, C.
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save
  • Efficacy and safety of ceritinib in patients with advanced anaplastic lymphoma kinase (ALK)-rearranged (ALK+) non-small cell lung cancer (NSCLC): An update of ASCEND-1
    Meeting Abstract

    Kim, D.; Mehra, R.; Tan, D. S. W.; Felip, E.; Chow, L. Q. M.; Camidge, D. R.; Vansteenkiste, J.; Sharma, S.; De Pas, T.; Riely, G. J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save